Founded 2003 Number of employees 1,200 | Industry Medical Technology CEO David C. Paul (2003–) Revenue 544.8 million USD (2015) | |
 | ||
Traded as NYSE: GMEDS&P 400 Component Key people David C. Paul(Chairman/CEO/Co-Founder)Anthony L Williams(President)A Brett Murphy(President:Commercial Ops)David M. Demski(President:Emerging Technologies) Stock price GMED (NYSE) US$ 27.42 -0.08 (-0.29%)14 Mar, 4:02 PM GMT-4 - Disclaimer Headquarters Pennsylvania, United States Subsidiaries Transplant Technologies of Texas, Ltd. | ||
Globus medical excelsius precruiting
Globus Medical, Inc., based in Audubon, PA, is a medical device company focused on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical is a publicly traded company and is listed on the NYSE under the symbol GMED.
Contents
Products
The company's products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are uses in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Globus Medical to date has developed a portfolio of spine products, releasing more than 150 products.
Acquisitions
January 8, 2014 Globus Medical, Inc announced that it has acquired Excelsius Surgical.The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy"
October 23, 2014 Globus Medical acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT is a provider of human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
February 26, 2015, Globus Medical acquired Branch Medical Group, a third party manufacturer of high precision medical devices.
July 26, 2016 ,Globus Medical acquired Alphatec Holdings, Inc international operations and distribution channel for a purchase price of $80 million. As part of the transaction, Globus has also agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
Recognition
Globus Medical ranked #27 in Forbes Lists of America's Best Small Companies (2013)